Literature DB >> 2828216

Mucinous carcinoma of the rectum.

O Sasaki1, W S Atkin, J R Jass.   

Abstract

We have studied and compared 316 mucinous and 45 signet ring cell carcinomas of the rectum with 413 non-mucinous carcinomas. Mucinous carcinomas were subdivided according to the amount of mucus which was gauged subjectively as either more or less than 75% of the tumour volume. Five year survivals for non-mucinous, mucinous (less than 75%), mucinous (greater than 75%) and signet ring cell carcinoma were 62%, 60%, 53% and 13%. Mucinous carcinomas (less than 75%) were relatively well differentiated and showed an age distribution identical to their non-mucinous counterparts, but differed in their strong association with villous adenoma. Mucinous carcinomas (greater than 75%) were less well differentiated and, like signet ring cell carcinomas, occurred in younger patients and showed no special association with villous adenoma. Clinically important and independent predictive variables were found by the method of multivariate regression analysis to be number of lymph node metastases, extent of spread in continuity, character of invasive margin and peritumoural lymphocytic infiltration. After adjustment for these factors, typing of rectal cancer as mucinous, non-mucinous and signet ring cell gave no additional, clinically useful prognostic information.

Entities:  

Mesh:

Year:  1987        PMID: 2828216     DOI: 10.1111/j.1365-2559.1987.tb02631.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  26 in total

1.  Systematic review of prognostic importance of extramural venous invasion in rectal cancer.

Authors:  Manish Chand; Muhammed R S Siddiqui; Ian Swift; Gina Brown
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Familial colorectal cancer: discussion paper.

Authors:  M J Underwood; V W Johnson
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

3.  HNPCC-associated synchronous early-stage signet-ring cell carcinomas of colonic origin. A comparative morphological and immunohistochemical study of an intramucosal and a submucosal example.

Authors:  Louise Klarskov; Inge Bernstein; Susanne Holck
Journal:  Virchows Arch       Date:  2008-11-11       Impact factor: 4.064

4.  Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.

Authors:  John R Hyngstrom; Chung-Yuan Hu; Yan Xing; Y Nancy You; Barry W Feig; John M Skibber; Miguel A Rodriguez-Bigas; Janice N Cormier; George J Chang
Journal:  Ann Surg Oncol       Date:  2012-04-04       Impact factor: 5.344

Review 5.  Reporting colorectal cancer.

Authors:  J R Jass; B C Morson
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 6.  Mucinous carcinoma of the rectum: a distinct clinicopathological entity.

Authors:  M Chand; S Yu; R I Swift; G Brown
Journal:  Tech Coloproctol       Date:  2013-12-11       Impact factor: 3.781

7.  Effect of mucin production on survival in colorectal cancer: a case-control study.

Authors:  Mirna H Farhat; Kassem A Barada; Ayman N Tawil; Doha M Itani; Hassan A Hatoum; Ali I Shamseddine
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Overall survival is improved in mucinous adenocarcinoma of the colon.

Authors:  J Hogan; J P Burke; G Samaha; E Condon; D Waldron; P Faul; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2014-01-15       Impact factor: 2.571

9.  Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.

Authors:  V C Petersen; K J Baxter; S B Love; N A Shepherd
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Survival with colorectal cancer in ulcerative colitis. A study of 102 cases.

Authors:  A Sugita; A J Greenstein; M B Ribeiro; D B Sachar; C Bodian; A K Panday; A Szporn; J Pozner; T Heimann; M Palmer
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.